Stefan Kloiber MD
University:
University of Toronto
Principal Faculty:
Psychiatry
Principal Department/Program:
Psychiatry
Principal Hospital Appointment:
Centre for Addiction and Mental Health
Key Publications:
1. Ahmed M, Best LM, Pereira CF, Boileau I, Kloiber S. Effects of endocannabinoid system modulation on social behaviour: A systematic review of animal studies. Neurosci Biobehav Rev. 2022 Jul;138:104680. doi: 10.1016/j.neubiorev.2022.104680. Epub 2022 May 2. IF 9.052. Senior Author. 2. Kim HK, Gonçalves VF, Husain MI, Müller DJ, Mulsant BH, Zai G, Kloiber S. Cross-disorder GWAS meta-analysis of endocannabinoid DNA variations in major depressive disorder, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorder, and schizophrenia. Psychiatry Res. 2023 Dec;330:115563. IF 11.3. Senior Author. 3. Kim HK, Banik S, Husain MI, Tang V, Levitan R, Daskalakis ZJ, Kloiber S. Systematic review of structured care pathways in major depressive disorder and bipolar disorder. BMC Psychiatry. 2023 Feb 2;23(1):85. IF 4.4. Senior Author. 4. Kloiber S, Jones BDM, Hodsoll J, Chaudhry IB, Khoso AB, Husain MO, Ortiz A, Goldstein BI, Husain N, Mulsant BH, Young AH, Husain MI (2021). Metabolic function in patients with bipolar depression receiving anti-inflammatory agents: findings from the MINDCARE study, a multicentre, randomised controlled trial. J Affect Disord. 2022 Feb 15;299:135-141. doi: 10.1016/j.jad.2021.11.032. IF 4.839. First Author. Ahmed M, Boileau I, Le Foll B, Carvalho A, Kloiber S. The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics. Brazilian Journal of Psychiatry. Braz J Psychiatry. 2022 Jan-Feb;44(1):81-93. doi: 10.1590/1516-4446-2021-1926. IF 3.000. Senior Author.